Literature DB >> 6375306

Properties of a high molecular weight neutrophil chemotactic factor, possibly derived from mast cells: evidence for chemokinetic rather than chemotactic activity.

D R Cundell, I Moodley, R J Davies.   

Abstract

Kay and his colleagues [1] have suggested that the neutrophil high molecular weight chemotactic factor ( NCF ) found in the serum of patients suffering from a variety of allergic diseases is mainly derived from mast cells and is therefore an indicator of mast cell activation. We have studied some of the properties of NCF obtained from patients with atopic extrinsic asthma and compared it with N-formyl-1-methionyl-1-leucyl-1-phenyl-alanine (FMLP), a chemotactic peptide [2]. A number of differences between FMLP and NCF were observed. In contrast to FMLP, checkerboard analysis showed that NCF caused random migration of neutrophils. In addition microscopic analysis of neutrophil locomotion in response to FMLP demonstrated the characteristic pseudopod formation. Furthermore, it was found that in contrast to FMLP, NCF did not cause the release of lysosomal enzymes from cytochalasin B-treated neutrophils. These results suggest that NCF has chemokinetic rather than chemotactic properties.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6375306     DOI: 10.1007/bf01973855

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  12 in total

1.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

2.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

3.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

4.  Mediator release in local heat urticaria.

Authors:  P C Atkins; B Zweiman
Journal:  J Allergy Clin Immunol       Date:  1981-10       Impact factor: 10.793

5.  Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma.

Authors:  T H Lee; L Nagy; T Nagakura; M J Walport; A B Kay
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Neutrophil bipolar shape formation in whole blood. A simple and rapid method for the assessment of neutrophil leukocyte responsiveness.

Authors:  D F Jadwin; C W Smith; T R Meadows
Journal:  Am J Clin Pathol       Date:  1981-10       Impact factor: 2.493

7.  Histamine, neutrophil chemotactic factor and circulating basophil levels following exercise in asthmatic and control subjects.

Authors:  D J Morgan; M J Phillips; I Moodley; E V Elliott; R J Davies
Journal:  Clin Allergy       Date:  1982-10

8.  Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.

Authors:  J Palmblad; C L Malmsten; A M Udén; O Rådmark; L Engstedt; B Samuelsson
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors.

Authors:  S H Zigmond
Journal:  J Cell Biol       Date:  1977-11       Impact factor: 10.539

View more
  1 in total

1.  Occupational asthma in a hairdressing salon.

Authors:  A D Blainey; S Ollier; D Cundell; R E Smith; R J Davies
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.